209
1. Alam R, Fathema K, Lamia Nahid K, Sarkar N, Rukunuzzaman M. Possible Predictors of Adverse Outcomes in Children with Acute Viral Hepatitis in a Low-Middle-Income Country. Turk Arch Pediatr. Published online October 23, 2025:616. doi:10.5152/TurkArchPediatr.2025.25124
2. Alfares BA, Bokkers RPH, Verkade HJ, et al. Portal vein obstruction after pediatric liver transplantation: A systematic review of current treatment strategies. Transplant Rev. 2021;35(4):100630. doi:10.1016/j.trre.2021.100630
3. Almuqbel MM, Abousrafa S, Omara W, et al. Quantitative MRI iron load assessment in β-thalassemia patients beyond the liver and heart: A systematic review. Eur J Radiol. 2026;194:112537. doi:10.1016/j.ejrad.2025.112537
4. Ashkenazi S. Size of Liver Edge in Full-Term, Healthy Infants. Arch Pediatr Adolesc Med. 1984;138(4):377. doi:10.1001/archpedi.1984.02140420043015
5. Attina’ G, Triarico S, Romano A, Maurizi P, Mastrangelo S, Ruggiero A. Role of Partial Splenectomy in Hematologic Childhood Disorders. Pathogens. 2021;10(11):1436. doi:10.3390/pathogens10111436
6. Bains V, Joshi D. An Overview of Paediatric Autoimmune and Genetic Cholestatic Liver Disease for the Adult Physician. Clin Med. Published online November 2025:100533. doi:10.1016/j.clinme.2025.100533
7. Barak G, Demmler-Harrison G, Rossetti L, Tubman VN, Walimbe AS, Asaithambi R. Progressive Thrombocytopenia, Splenomegaly, and Abnormal Tone in an Infant With Growth Faltering. Pediatrics. 2024;154(1):e2023064048. doi:10.1542/peds.2023-064048
8. Bernts LHP, Drenth JPH, Tjwa ETTL. Management of portal hypertension and ascites in polycystic liver disease. Liver Int. 2019;39(11):2024-2033. doi:10.1111/liv.14245
9. Bhushan B, Borude P, Edwards G, et al. Role of Bile Acids in Liver Injury and Regeneration following Acetaminophen Overdose. Am J Pathol. 2013;183(5):1518-1526. doi:10.1016/j.ajpath.2013.07.012
10. Brum NFF, Coelho JS, Carvalho LS, et al. Hemophagocytic lymphohistiocytosis and visceral leishmaniasis in children: a series of cases and literature review. Rev Paul Pediatr. 2022;40:e2020269. doi:10.1590/1984-0462/2022/40/2020269
11. Cathcart J, Barrett R, Bowness JS, Mukhopadhya A, Lynch R, Dillon JF. Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD : A Systematic Review. Liver Int. 2025;45(4):e16127. doi:10.1111/liv.16127
12. Chaudhry SR, Luskin V, Panuganti KK. Anatomy, Abdomen and Pelvis, Spleen. In: StatPearls. StatPearls Publishing; 2025. Accessed November 28, 2025. http://www.ncbi.nlm.nih.gov/books/NBK482235/
13. Childs JT, Esterman AJ, Thoirs KA, Turner RC. Ultrasound in the assessment of hepatomegaly: A simple technique to determine an enlarged liver using reliable and valid measurements. Sonography. 2016;3(2):47-52. doi:10.1002/sono.12051
14. Costagliola G, De Marco E, Consonni F, et al. Inborn errors of immunity presenting with lymphoproliferation: lessons from a case series. Ann Hematol. 2025;104(6):3117-3127. doi:10.1007/s00277-025-06456-1
15. Costagliola G, De Marco E, Massei F, et al. The Etiologic Landscape of Lymphoproliferation in Childhood: Proposal for a Diagnostic Approach Exploring from Infections to Inborn Errors of Immunity and Metabolic Diseases. Ther Clin Risk Manag. 2024;Volume 20:261-274. doi:10.2147/TCRM.S462996
16. Curovic Rotbain E, Lund Hansen D, Schaffalitzky De Muckadell O, Wibrand F, Meldgaard Lund A, Frederiksen H. Splenomegaly – Diagnostic validity, work-up, and underlying causes. Bertolini F, ed. PLOS ONE. 2017;12(11):e0186674. doi:10.1371/journal.pone.0186674
17. Diaz GJ. Basolateral and canalicular transport of xenobiotics in the hepatocyte: A review. Cytotechnology. 2000;34(3):225-235. doi:10.1023/A:1008152205697
18. Ferreira CR, Cassiman D, Blau N. Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases. Mol Genet Metab. 2019;127(2):117-121. doi:10.1016/j.ymgme.2019.04.002
19. Funaki T, Yamada M, Ide K, et al. Etiology of Severe Acute Hepatitis in a Pediatric Transplant Center in Japan. J Pediatr Infect Dis Soc. 2023;12(4):248-251. doi:10.1093/jpids/piad021
20. Gielchinsky Y, Elstein D, Hadas-Halpern I, Lahad A, Abrahamov A, Zimran A. Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher disease. Br J Haematol. 1999;106(3):812-816. doi:10.1046/j.1365-2141.1999.01616.x
21. Griffin S. Feline abdominal ultrasonography: What’s normal? What’s abnormal? The spleen. J Feline Med Surg. 2021;23(3):241-255. doi:10.1177/1098612X21993658
22. Guan YS, Hu Y. Clinical Application of Partial Splenic Embolization. Sci World J. 2014;2014:1-9. doi:10.1155/2014/961345
23. Henrar RB, Vuijk FA, Burchell GL, et al. Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2025;26(5):1978. doi:10.3390/ijms26051978
24. Jerves Serrano T, Gold J, Cooper JA, et al. Hepatomegaly and Splenomegaly: An Approach to the Diagnosis of Lysosomal Storage Diseases. J Clin Med. 2024;13(5):1465. doi:10.3390/jcm13051465
25. Kahramaner Z, Erdemir A, Arik B, Bilgili G, Tekin M, Genc Y. Reference ranges of liver and spleen dimensions in term infants: sonographic measurements. J Med Ultrason. 2015;42(1):77-81. doi:10.1007/s10396-014-0578-0
26. Konuş OL, Ozdemir A, Akkaya A, Erbaş G, Celik H, Işik S. Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography. Am J Roentgenol. 1998;171(6):1693-1698. doi:10.2214/ajr.171.6.9843315
27. Lamireau T, McLin V, Nobili V, Vajro P. A practical approach to the child with abnormal liver tests. Clin Res Hepatol Gastroenterol. 2014;38(3):259-262. doi:10.1016/j.clinre.2014.02.010
28. Lasagni A, Cadamuro M, Morana G, Fabris L, Strazzabosco M. Fibrocystic liver disease: novel concepts and translational perspectives. Transl Gastroenterol Hepatol. 2021;6:26-26. doi:10.21037/tgh-2020-04
29. Loloi J, Patel A, McDevitt P, Bruno MA, Riley T. How Strongly Do Physical Examination Estimates and Ultrasonographic Measurements of Liver Size Correlate? A Prospective Study. Am J Med. 2019;132(1):103-108. doi:10.1016/j.amjmed.2018.09.012
30. Martin A, Thompson AA. Thalassemias. Pediatr Clin North Am. 2013;60(6):1383-1391. doi:10.1016/j.pcl.2013.08.008
31. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606-616. doi:10.1038/nri1669
32. Mehta A, Kuter DJ, Salek SS, et al. Presenting signs and patient co‐variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED‐C) Delphi initiative. Intern Med J. 2019;49(5):578-591. doi:10.1111/imj.14156
33. Meroueh C, Warasnhe K, Tizhoosh HR, Shah VH, Ibrahim SH. Digital pathology and spatial omics in steatohepatitis: Clinical applications and discovery potentials. Hepatology. 2025;82(6):1619-1644. doi:10.1097/HEP.0000000000000866
34. Mpakogiannis K. Evaluating spleen volume in inflammatory bowel disease. Ann Gastroenterol. Published online 2025. doi:10.20524/aog.2025.0993
35. Nowak K, Paluch M, Cudzik M, Syska K, Gawlikowska W, Janczura J. From steatosis to cirrhosis: the role of obesity in the progression of liver disease. J Diabetes Metab Disord. 2025;24(2):227. doi:10.1007/s40200-025-01754-x
36. Ostojic A, Petrovic I, Silovski H, Kosuta I, Sremac M, Mrzljak A. Approach to persistent ascites after liver transplantation. World J Hepatol. 2022;14(9):1739-1746. doi:10.4254/wjh.v14.i9.1739
37. Otake S, Ikenoue C, Sudani N, et al. National Surveillance of Pediatric Acute Hepatitis of Unknown Etiology, Japan, October 2021–December 2022. Emerg Infect Dis. 2023;29(6). doi:10.3201/eid2906.221579
38. Podymova SD. [Acute hepatitis in infectious diseases]. Eksp Klin Gastroenterol Exp Clin Gastroenterol. 2013;(4):38-43.
39. Sarma MS, Seetharaman J. Pediatric non-cirrhotic portal hypertension: Endoscopic outcome and perspectives from developing nations. World J Hepatol. 2021;13(10):1269-1288. doi:10.4254/wjh.v13.i10.1269
40. Sato A, Alogakos M, Burns JWF, et al. Laparoscopic versus open splenectomy in non-traumatic pediatric patients: a systematic review and meta-analysis. Pediatr Surg Int. 2025;41(1):317. doi:10.1007/s00383-025-06208-2
41. Spogis J, Grözinger G. Interventional Radiology Management of Pediatric Portal Venous Pathologies. Tech Vasc Interv Radiol. 2025;28(4):101085. doi:10.1016/j.tvir.2025.101085
42. Suttorp M, Classen CF. Splenomegaly in Children and Adolescents. Front Pediatr. 2021;9:704635. doi:10.3389/fped.2021.704635
43. Tidwell J, Wu GY. Heritable Chronic Cholestatic Liver Diseases: A Review. J Clin Transl Hepatol. 2024;000(000):000-000. doi:10.14218/JCTH.2024.00119
44. Tong WL, Gadani S. Chronic Portal Vein Thrombosis: Diagnosis, Management, and Review of the Literature. Tech Vasc Interv Radiol. 2025;28(4):101084. doi:10.1016/j.tvir.2025.101084
45. Trauner M, Boyer JL. Bile Salt Transporters: Molecular Characterization, Function, and Regulation. Physiol Rev. 2003;83(2):633-671. doi:10.1152/physrev.00027.2002
46. Ulu K, Aliyev E, Kılıç Könte E, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy. Rheumatology. 2024;63(SI2):SI167-SI172. doi:10.1093/rheumatology/keae124
47. Vancauwenberghe T, Snoeckx A, Vanbeckevoort D, Dymarkowski S, Vanhoenacker F. Imaging of the spleen: what the clinician needs to know. Singapore Med J. 2015;56(03):133-144. doi:10.11622/smedj.2015040
48. Wang C, Saboor S, Zhang Y, Li G, Jiang C. Comprehensive insights into pediatric infectious mononucleosis: a retrospective study. J Infect Dev Ctries. 2025;19(09):1359-1369. doi:10.3855/jidc.21351
49. Wu J, Deng X, Luo J, et al. Update in the treatment of cirrhotic patients with portal vein thrombosis. Clin Mol Hepatol. 2025;31(4):1139-1166. doi:10.3350/cmh.2025.0411
50. Zhao Y, Li Z, Zhang L, et al. Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein–Barr virus (EBV)-related hemophagocytic lymphohistiocytosis. Medicine (Baltimore). 2020;99(1):e18503. doi:10.1097/MD.0000000000018503